Logo
x

Search

Subscribe Now

AngioDynamics

AngioDynamics Commences the RECOVER-AV Study of AlphaVac F1885 System to Treat Pulmonary Embolism

AngioDynamics Commences the RECOVER-AV Study of AlphaVac F1885 System to Treat Pulmonary Embolism

  • September 20, 2024
AngioDynamics’ AlphaVac F18⁸⁵ System Gains the US FDA’s Clearance to Treat Pulmonary Embolism

AngioDynamics’ AlphaVac F18⁸⁵ System Gains the US FDA’s Clearance to Treat Pulmonary Embolism

  • April 4, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.